"10.1371_journal.pone.0013050","plos one","2010-09-30T00:00:00Z","Aman P Mann; Anoma Somasunderam; Ren√© Nieves-Alicea; Xin Li; Austin Hu; Anil K Sood; Mauro Ferrari; David G Gorenstein; Takemi Tanaka","Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center at Houston, Houston, Texas, United States of America; Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, United States of America; Department of Biomedical Engineering, University of Texas Austin, Austin, Texas, United States of America; Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America; Department of Bioengineering, Rice University, Houston, Texas, United States of America; Department of Gynecologic Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America; Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America; Department of Pharmaceutical Sciences, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America","Conceived and designed the experiments: APM AS DG TT. Performed the experiments: APM AS XL AH TT. Analyzed the data: APM AS RNA TT. Contributed reagents/materials/analysis tools: AS MF. Wrote the paper: APM AS RNA TT.","D.G. has financial interest in AM Biotechnologies and AptaMed Inc. A.M, A.S., D.G, and T.T are inventors on a patent on ESTA-1 in preparation. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2010","09","Aman P Mann","APM",9,TRUE,4,5,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
